Pharming Group N.V. reported earnings results for the fourth quarter and full year ended December 31, 2025. For the fourth quarter, the company reported sales was USD 106.5 million compared to USD 92.7 million a year ago. Net income was USD 5.3 million compared to USD 2.9 million a year ago. Basic earnings per share from continuing operations was USD 0.008 compared to USD 0.004 a year ago. Diluted earnings per share from continuing operations was USD 0.007 compared to USD 0.004 a year ago.
For the full year, sales was USD 376.13 million compared to USD 297.2 million a year ago. Net income was USD 2.85 million compared to net loss of USD 11.84 million a year ago. Basic earnings per share from continuing operations was USD 0.004 compared to basic loss per share from continuing operations of USD 0.018 a year ago. Diluted earnings per share from continuing operations was USD 0.004 compared to diluted loss per share from continuing operations of USD 0.018 a year ago.